4 Cannabis Stocks Heating Up The Markets

The cannabis sector gained one if its biggest votes of confidence to date when top Wall Street firm Bank of America -Merrill Lynch initiated coverage on four of the top cannabis stocks with mostly positive outlook for sector.  BofA is the latest of the Wall Street firms to add cannabis to their coverage, following the likes of Cowen, Jefferies and Piper Jaffray.

cannabisstocks.jpg

Cannabis stocks, for the most part, have started the year off on a strong foot with the Horizons’ Marijuana Life Sciences ETF (HMMJ) (HMLSF), the largest and most representative cannabis exchange traded fund, up about 45%.  As the cannabis sector continues to break new boundaries, investors seeking opportunities in the budding sector may benefit from keeping tabs on several cannabis stocks.

Leafbuyer Technologies, Inc. (LBUY), a leading cannabis technology and marketing platform that connects consumers to dispensaries and product companies, announced the establishment of the company’s first satellite office in Los Angeles, California. The new office is in addition to its original Denver Colorado headquarters and will become the primary regional office for several western states. This move will help Leafbuyer expand its national footprint by enabling sales initiatives to focus on newly legal Midwestern and Eastern states.

“California is now a mature recreational and medical cannabis market, which makes this the opportune time to establish a secondary operation in the southern part of this industry-leading state,” said Kurt Rossner, CEO.

Leafbuyer recently announced that its quarterly cash sales growth rose 36% year over year in the quarter ending March 31, 2019. The cannabis stock attributes this success to platform enhancements, order ahead and Leafbuyer loyalty as well as a multi-state sales team.  The platform allows consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at numerous participating dispensaries Leafbuyer plans to continue to expand its reach into newly legal US markets, while increasing consumer retention to boost bottom line revenues.

Canopy Growth Corporation (CGC) (WEED), a world-leading diversified cannabis and hemp company, is rumored to be preparing to purchase Acreage Holdings Inc, a U.S. cannabis company, by buying the right to purchase, according to Bloomberg and CNBC.  If Canopy Growth was to acquire the US-based cannabis company now, it would be delisted from the TSE since cannabis is illegal in the U.S., and the exchange does not allow companies to own stakes in businesses that run illegal operations.  Instead, Canopy Growth will purchase the rights to buy Acreage if or when cannabis becomes legal in the U.S. at an agreed-upon price, according to the source.

Bank of America (BAC) initiated new coverage Canopy Growth giving it a buy rating with a price target of $52.  On Tuesday, Co-CEO Bruce Linton updated the company’s revenue guidance at a cannabis conference in Toronto in which Canopy is anticipating at least $744 million in revenue in fiscal 2020, beating analyst estimates by 19 percent. The company also announced the completion of an all-cash acquisition of Spain-based licensed cannabis producer Cáñamo y Fibras Naturales, S.L. (Cafina). The acquisition paves the way for Canopy to expand its European production footprint.

“Operating multiple production assets within Europe will allow us to increase revenue in the EU free of supply constraints,” commented Mark Zekulin, President & Co-CEO. “This strategic acquisition in a scalable, low-cost production environment diversifies our owned production capabilities in Europe, similar to our approach in Canada where we have production facilities in seven different provinces. Adding Cafina will allow us to quickly build out our presence in Spain using its existing cultivation licence as a launch pad, while ensuring our Canadian footprint – the largest in the world – can continue to serve the medical and recreational needs of Canadians.”

HEXO Corp (HEXO), consumer packaged goods cannabis company, had Bank of America (BAC) initiated coverage on the stock giving it a buy rating and the title of its top cannabis stock pick.  Most recently, the company announced reaching a significant milestone of completing the first harvest in its 1 million sq. ft. expansion.

“Completing the first harvest in our 1,000,000 sq. ft. greenhouse expansion showcases the dedication and hard work of the entire HEXO team,” said Sébastien St-Louis, CEO and co-founder. “We are very proud of our continued ability to execute on our plans, creating value for our shareholders and demonstrating our commitment to our customers. This cultivation milestone means that an expanded HEXO product offering will be available to more Canadians shortly.”

In mid-March, HEXO announced a definitive arrangement agreement to acquire Newstrike Brands Ltd. (NWKRF) in a stock deal valued C$263 million ($196.7 million). This acquisition which will boost HEXO’s production capacity to 150,000 kg annually while increasing its domestic market access to 9 provinces.

Aurora Cannabis Inc. (ACB), a world leading cannabis company, also had Bank of America (BAC) initiate coverage on it stock giving it a buy rating and price target of $11. The company announced that, further to its April 5th press release, the public appeal process related to the German cannabis production tender has been completed, and Aurora’s contract with the German Federal Institute for Drugs and Medical Devices has been finalized allowing Aurora to begin construction on a new indoor cannabis production facility in May.

“We are thrilled with the positive outcome of the tender process, and excited to start construction on our latest production facility,” said Neil Belot, Chief Global Business Development Officer. “We are very proud of the work done by our European team.  In addition to providing German medical patients with a local supply of high-quality, medical grade cannabis, this new facility will also bring additional new jobs to the German labour market. It’s a strong validation of our production and distribution standards to have been recognized as having the highest-rated overall concept out of 79 tender applications, and we look forward to continuing to increase availability of medical cannabis in this important market.”

Also this week, Aurora announced entering a binding letter agreement with Hempco Food and Fiber Inc. (HEMP), a provider of hemp-based foods, fiber and nutraceuticals.  Per the agreement, Aurora will acquire all of the issued and outstanding common shares not already owned of Hempco and pay $1.04 per share in common shares of Aurora, for a valuation of C$63.4 million.

marijuanastocks.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018, and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam has been compensated an additional $100,000 by Leafbuyer Technologies for a period of coverage from April 12, 2019 to June 12, 2019. Midam owned 77,000 shares of Leafbuyer Technologies. Midammay buy or sell additional shares of (LBUY) in the open market at any time (as of 3/29/2019) Midam Ventures no longer owns 77,000 shares of (LBUY), including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Click here for full Midam disclaimer.

4 Marijuana Stocks To Watch This Week

The Horizons’ Marijuana Life Sciences ETF (HMMJ) (HMLSF) is the largest and most representative marijuana exchange traded fund in the markets. The fund strives to duplicate, to an extent, the performance of the North American Marijuana Index (NAMI). The NAMI was designed to track the performance of a basket of North American life sciences companies with a focus of their operations in the marijuana industry.

marijuana.jpg

Marijuana stocks, for the most part, have started the year off on a strong note as this marijuana ETF has risen 45% year to date.  As lawmakers advocate for legislative changes in favor of marijuana legalization and the adoption of marijuana for medical purposes rises, the sector has responded favorably.  Investors seeking opportunities in th budding  marijuana sector may benefit from keeping tabs on several marijuana stocks.

Leafbuyer Technologies, Inc. (LBUY), a leading cannabis technology and marketing platform that connects consumers to dispensaries and product companies, announced that its quarterly cash sales growth rose 36% year over year in the quarter ending March 31, 2019. The company attributes this success to mainly to platform enhancements, order ahead and Leafbuyer loyalty as well as a multi-state sales team.  The company’s go forward plan is to continue to expand into newly legal US markets, while increasing consumer retention to boost bottom line revenues.

“This growth provides momentum and a solid foundation for 2019. As we increase our national footprint and expand our industry leading platform, we’re forecasting significant sales gains through the remainder of the year,” said Kurt Rossner, CEO.

Last month. Leafbuyer announced that the number of its Greenlight platform users has reached nearly 80,000.  The platform allows consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at participating dispensaries. At the time of this news release, the number of Leafbuyer dispensary clients with capabilities grew to 60 dispensaries, located throughout the states of California, Colorado, Oklahoma, and Michigan.

Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the health & wellness, announced that it has been working to resolve its 9.5% convertible notes due April 2019 and intends to repay the notes with cash from a business transaction as well as the net proceeds of a planned equity investment from long-term investor Foris Ventures.

“We are pleased with the support of our long term investors in supporting our plans to pay off this debt,” said John Melo, Amyris President and CEO. “We believe this pathway toward retiring our April 2019 debt should mitigate some of the dilutive impact on equity and we will provide more details and an update when this process is complete.”

At the end of March, Amyris announced stated it will discuss at an April 15 conference its previously disclosed cannabinoid development, licensing and commercialization agreement containing $300 million of R&D and milestone payments and a long-term royalty stream. Since, the company reached its first milestone for its cannabinoid partner, LAVVAN. They brought in the first payment of $10 million, which is part of a $300 million collaboration before future royalty payments.

Aphria Inc. (APHA) , a leading global cannabis company, announced fiscal third-quarter earnings reporting a loss as the company booked a C$58 million impairment charge and an additional C$30 million in operating losses. For the quarter ended Feb. 28th, Aphria reported a loss of $0.20 per share, compared to earnings of $0.08 per share for the year earlier.  However, the company reported that total revenue grew by 617% to $73.6 million compared to the $10.3 million the year prior.

“Our organization has experienced significant change in a very short period of time which was necessary to propel the Company forward. Aphria will continue to drive sustainable long-term shareholder value by leveraging its strong brand positioning, superior distribution model, product innovation, industrial scale cultivation and automation, medical-use leadership and strategic global platform” stated Irwin D. Simon, Chairman and Interim CEO.

The company also provided an update that it has entered into a series of transactions that will accelerate the expiration of an unsolicited takeover offer from Green Growth Brands to April 25. The transactions will provide up to an additional $89 million of liquidity without dilution to shareholders, according to the company.

Aurora Cannabis Inc. (ACB), a world leading cannabis company, provided an update on the status of Aurora Sun, the company’s latest and largest Sky Class facility which is currently under construction in Alberta. Aurora Sun will now be expanded by 33% from its original plans totaling to 1.62 million square feet to meet consumer demands. Aurora projects an expected production capacity at Aurora Sun in excess of 230,000 kg of high-quality cannabis annually.

“Aurora Sun represents the next evolution in our Sky Class facility design, delivering massive scale, low cost production, and consistent, high-quality cannabis,” said Terry Booth, CEO. “The increased scale of Aurora Sun reflects our expectations for the long-term growth in global demand, especially the higher margin international medical markets which will be faced with significant supply shortages for the foreseeable future. Sun is also designed with flexibility in mind to enable us to quickly meet changing market demands, particularly as breeding and cultivation technologies evolve and as customer preferences and requirements change.”

cannabisstocks1.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018, and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam has been compensated an additional $100,000 by Leafbuyer Technologies for a period of coverage from April 12, 2019 to June 12, 2019. Midam may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc.. Click here for full Midam disclaimer.

3 Marijuana Stocks Making Headlines

North America is by far the leader of the cannabis industry, as it is not only the fastest growing region but also possesses the largest market share.  Canada became the first G7 nation to legalize adult-use recreational cannabis and the influx of United States legalizing one form or another of cannabis as well the passing of the 2018 US Farm Bill, which legalized hemp, is driving the growth of the sector. The two countries, together, command the global cannabis industry, which is forecast to hit $146.4 billion across the globe by 2025, with a compound annual growth rate of 34.6%, according to a Grand View Research report.

marijuana.jpg

The increased legalization of cannabis along with the growing utilization in several medical applications are key factors for driving the growth of the industry.   As the cannabis industry continues to evolve, there are several marijuana stocks making headlines.

Leafbuyer Technologies, Inc. (LBUY) announced that the number of Greenlight platform users has reached nearly 80,000, further to its recent release announcing Leafbuyer’s launch of the Greenlight app in Colorado and Oklahoma. The platform permits consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at participating dispensaries. Presently, the number of Leafbuyer dispensary clients with capabilities has grown to a total of 60, located throughout the states of California, Colorado, Oklahoma, and Michigan.

“The rapid geographic implementation of the Greenlight technology and the large number of users is encouraging. Developments are under way to bring new features to the platform that are expected to be a catalyst for continued revenue growth,” said Kurt Rossner, CEO of Leafbuyer. “We plan to expand the footprint further and optimize this technology to make it a staple in every legal market across the country.”

This news followed the announcement that Leafbuyer and Greenlight now integrate with Flowhub’s point of sale and compliance technology, giving customers have access to immediate, up-to-date menu information regarding product availability in dispensaries using Flowhub API and Leafbuyer platforms.

Curaleaf Holdings, Inc. (CURLF) (CURA.CN) on its recent earnings conference, company executives said CVS Health Corp (CVS) will start offering its Curaleaf Hemp lotions and transdermal patches in around 800 stores across the U.S. Today the company annouced the opening of its 23rd Florida dispensary as it continues to expand rapidly throughout the state. Curaleaf has the largest cannabis dispensary footprint in the US, now with 43 dispensaries across the country.

“As Curaleaf continues to deliver on its expansion strategy, we are well positioned to improve the quality of patients’ lives by providing access to safe top-quality cannabis products,” shared Joe Lusardi, Curaleaf CEO.

The dispensary includes the community’s first medical marijuana drive-thru. Curaleaf was the first in the state to introduce and test the drive-thru concept at its Palm Harbor dispensary and since has launched a second drive-thru in Orlando.   Today, Curaleaf also announced it will celebrate its grand opening on Thursday, March 21 from 3pm until 7pm at its Gainesville dispensary.

Canopy Growth Corporation (CGC) (WEED) announced it has acquired AgriNextUSA, a hemp enterprise led by CEO Geoff Whaling, to accelerate Canopy Growth’s entry into key American jurisdictions. As previously mentioned, Canopy Growth is on track to build the first Hemp Industrial Park in the Southern Tier of New York State, after receiving a state license to produce and process hemp. Canopy growth committed to invest $100M to $150M into a hemp operation as well as the production of high-quality CBD products.

“The United States is the next stop on Canopy Growth’s desired path to becoming a leading, revenue-generating company focused on all aspects of cannabinoids and their potential,” said Bruce Linton, co-CEO and Chairman. “Our significant investments, acquisitions and compilation of talented leaders such as Geoff will position us for swift expansion throughout the United States. By collaborating with a pioneer like Geoff, who has been involved with our team since our earliest days in 2013, we will aim to turn hemp supplied by American farmers into a wide range of products.”

This news followed Canopy’s announcement earlier this week of a two-year processing and extraction agreement Wednesday with HollyWeed Manufacturing & Extracts Inc.  The agreement entails that HollyWeed will process Canopy-supplied dried cannabis flower in its and in turn, HollyWeed will supply Canopy with oil and resin extracted from the source material. The companies expect the first shipment of product for extraction will take place in fall of 2019.

marijuanastocks.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018 and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam owns 77,000 shares of Leafbuyer Technologies. Midam may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Click here for full Midam disclaimer.

Marijuana Stocks To Watch As The Industry Evolves

The marijuana industry is expected to grow substantially over the next few years, with sales in the United States alone forecast to hit $23.4 billion by 2022, according to cannabis market research group Arcview. Presently, there are nine states, and the District of Columbia, that have legalized marijuana for recreational purposes and thirty states have given the green light for medicinal use.

In light of next month’s mid-term elections, four additional states will consider legalizing some type of marijuana use. Should all vote in favor of legalization, recreational marijuana will then become legal in eleven states and D.C, and in thirty-three for medicinal purposes.

Following the elections, the White House intends to tackle the federal marijuana reform, according to Rep. Dana Rohrabacher, R-Calif. Rohrabacher has stated that President Trump has spoken in support of legalizing medical marijuana on a federal level, while keeping the legalization of recreational marijuana in control of each state.

As the marijuana industry continues to break new boundaries, here are a few marijuana stocks to add to your watch-list.

Next Green Wave (NGW.CN)

Next Green Wave is a vertically integrated seed-to-consumer premium medicinal and recreational cannabis company operating in California and has been awarded permits for nursery, cultivation, extraction, and distribution. The company has acquired over 15 acres of cannabis-zoned development land and is in the process of building out four planned sites. Next Green Wave announced today that first phase of construction on its $8M state-of-the-art indoor facility is now 90% complete.

Earlier this week, Next Green Wave completed a letter of intent to acquire Loud Seeds, a six-time Cannabis Cup winner which has spent 20 years developing a vast collection of award-winning strains. In addition, the company has built a strong distribution list throughout the state and formed relationships with many other well-known cultivators and breeding partners.

“Being able to bring one of the best seed banks in the world into our nursery continues to differentiate Next Green Wave from other cultivators,” said Next Green Wave Executive Chairman, Leigh Hughes. “We are excited to join an award-winning genetics portfolio with world-class breeding skills as the construction of our facility nears completion and begins cultivation.”

Cronos Group (CRON) (CRON.TO)

Cronos is a globally diversified and vertically integrated cannabis company, with a presence across five continents, which operates two wholly-owned Canadian ACMPR-licensed producers: Peace Naturals Project Inc and Original BC Ltd.

The company will announce its financial results and hold its Third Quarter 2018 Earnings Conference Call on Tuesday, November13,2018 at 8:30 a.m. EDT. Senior management will be available for questions from the investment community after prepared remarks.

Recently, Cronos and Aleafia Health Inc. (ALEAF) (ALEF) annouced entering into a joint medical cannabis study to improve the management and treatment of insomnia and daytime sleepiness and a sponsored research agreement with the Technion Research and Development Foundation of the Technion — Israel Institute of Technology to explore the use of cannabinoids and their role in regulating skin health and skin disorders.

MedMen Enterprises, Inc. (MMNFF) (MMEN)

MedMen is leading cannabis company headquartered in the U.S. with assets and operations across the country. Most recently, a binding letter of intent was announced to purchase medical cannabis provider PharmaCann LLC in a stock deal valued at $682 million. The acquisition doubles the number of states where MedMen has licenses to 12 and combined, MedMen and PharmaCann would be licensed for 66 retail stores and 13 cultivation and production facilities.

MedMen released earnings for Fourth Quarter and Fiscal Year 2018, highlights include: a US market position with 12 states, 67 retail stores and 14 factories with pending PharmaCann acquisition, Q4 2018 systemwide revenue increase of 1,317% and a fiscal year 2018 systemwide revenue increase of 1,390%. MedMen plans to release its financial results for the first quarter fiscal 2019 ended September 30, 2018 after market close on November 29, 2018.

Canopy Growth Corp. (CGC) (WEED)

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. The company’s focus, aside from servicing the Canadian market with its numerous brands has been on expanding globally, with operations throughout eleven counties on five continents. Canopy is most well-known for beverage tycoon Constellation Brands (STZ) $4 billion-dollar investment, and 38% stake, into the marijuana company to develop cannabis-infused beverages.

Most recently, the company announced that TS Brandco, an indirect wholly-owned subsidiary of Canopy, purchased 10% of the issued and outstanding Class A common shares of 10006215 Manitoba Ltd., bringing TS Brandco’s total ownership of ManitobaCo to 89.9%, further enhancing Canopy subsidiaries’ market share of retail operations in the Manitoba province. This news followed the announcement of entering into an agreement to acquire the assets of ebbu, Inc., an Evergreen, Colorado -based hemp research company. The transaction will complement and accelerate multiple core verticals operating under Canopy Growth’s group of companies.

 


This blog is an affiliate of Midam Ventures LLC. Pursuant to an agreement between a Midam Ventures LLC and Next Green Wave (NGW), Midam expects to be paid a total of $1,075,000 for a period of six (6) months from October 1, 2018 and ending on April 1, 2019. The cash compensation will be paid out in increments monthly from the company to MIDAM. As of 10/01/2018 MIDAM has been paid a total of $150,000 from Next Green Wave (NGW). As MIDAM is paid by Next Green Wave (NGW) this disclaimer will update. Midam may buy or sell additional shares of (NGW) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Next Green Wave. Click here for full Midam disclaimer.

Are These Marijuana Stocks On Your Watch-List?

Shares of most cannabis stocks were broadly higher during premarket trade on Wednesday, leading to a rise in the marijuana indices and exchange traded funds. During premarket trade, the ETFMG Alternative Harvest ETF (MJ) rallied 1.7%, after taking in losses over 20% over the past six trading sessions. Keep in mind, the marijuana sector ETF has improved 22% over the past three months through Tuesday, while the S&P 500 (SPX) was down 2.8%.

Top Marijuana Stocks To Consider For Your Portfolio

The ETF holds around 40 stocks, including marijuana producers, pharmaceutical and biotech companies seeking the use of marijuana for medicinal purposes and consumer-oriented companies with an expertise in selling smokable products. The Top 5 Holdings of the ETFMG Alternative Harvest ETF include:

  • · Aurora Cannabis Corp. (ACB) (ACBFF)
  • · Canopy Growth Corporation (WEED) (CGC)
  • · Cronos Group Inc. (CRON)
  • · GW Pharmaceuticals Plc (GWPH)
  • · Tilray Inc. (TLRY)

The North American Marijuana Index, tracker of leading cannabis stocksthroughout North America, is holding onto gains of 137% over the last year. Even with the pullback seen among the sector, overall it is still outperforming the broad markets. With this in mind, investors continue to seek opportunities in numerous marijuana stocks.

More Opportunities Ahead For Cannabis Companies

The cannabis market has been really budding over the last year, and last week, Canada launched legal sales of recreational marijuana. It seems to be a promising time for cannabis companies, specifically North American. The legalization of recreational pot in Canada and California, earlier this year, may be setting the stage for more countries and/or states to “go green”.

With such a rapidly growing market like the cannabis industry, the potential to generate job opportunities and economic benefits heightens. According to an Arcview Market Research and BDS Analytics report, consumer spending on legal cannabis is forecast to reach USD $11 billion this year and by 2022 it’s anticipated to surpass USD $23 billion.

Alone, the U.S. cannabis industry is expected to create over 467,000 full-time equivalent jobs by 2022, which is over an 180% increase from 2017’s 170,000 full-time equivalent jobs. The typical grow house and “budtending” jobs are not the only occupations on the rise, opportunities in finance, compliance, and operations are wanted as well. As the cannabis industry continues to thrive, here are a few North American marijuana stocks to add to your watch-list.

3 Marijuana Stocks To Add To Your Watch-List

In one week from today, Canada make a historic move and legalize recreational marijuana on a national level. On October 17, adults aged 18 or 19, depending on the province, will be able to purchase and consume cannabis products for recreational purposes. The momentum that is being seen across the industry is like no other, especially as more “traditional” companies are seeking opportunities within the lucrative sector.

Constellation Brands (STZ) made headlines, not once but twice, as the first S&P 500 company to invest into the marijuana industry with its original stake, and again when it increased investment, into Canopy Growth Corp. (CGC) for marijuana-infused beverages. Even PepsiCo (PEP) stated that the company taking opportunities in the marijuana industry into consideration as other beverage makers like Coca Cola (KO) are rumored to be investigating the market. “I think we’ll look at it critically, but I’m not prepared to share any plans that we may have in the space right now,” PepsiCo’s CFO Hugh Johnston told reporters.

As anticipation of the market continues to build while the marijuana industry’s potential grows, are these marijuana stocks on your watch list this month?

Click Here For 3 Marijuana Stocks To Add To Your Watch-List